Effect of lactoperoxidase on the antimicrobial effectiveness of the thiocyanate hydrogen peroxide combination in a quantitative suspension test

BMC Microbiology

Volumn 9, Issue , 2009, Pages

  Welk, A ^a   Meller, Ch ^b   Schubert, R ^c   Schwahn, Ch ^a   Kramer, A ^a   Below, H ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; LACTOPEROXIDASE; THIOCYANATE; THIOCYANIC ACID DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BROTH DILUTION; CANDIDA ALBICANS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SALIVA LEVEL; FUNGUS GROWTH; IN VITRO STUDY; NONHUMAN; QUANTITATIVE ANALYSIS; REDUCTION KINETICS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS SANGUINIS; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIAL VIABILITY;

CANDIDA ALBICANS; FUNGI; STREPTOCOCCUS MUTANS;

CANDIDA ALBICANS; HUMANS; HYDROGEN PEROXIDE; LACTOPEROXIDASE; MICROBIAL VIABILITY; STREPTOCOCCUS MUTANS; STREPTOCOCCUS SANGUIS; THIOCYANATES;

EID: 68349144161     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-9-134     Document Type: Article

References (54)

1. Periodontal Disease in Pregnancy. I. Prevalence and Severity. H Loe J Silness, Acta Odontol Scand 1963 21 533 551 10.3109/00016356309011240 14121956
2. Plaque induced periodontal disease in beagle dogs. A 4-year clinical, roentgenographical and histometrical study. J Lindhe SE Hamp H Loe, J Periodontal Res 1975 10 5 243 255 10.1111/j.1600-0765.1975.tb00031.x 129548
3. On the prevention of caries and periodontal disease. Results of a 15-year longitudinal study in adults. P Axelsson J Lindhe B Nystrom, J Clin Periodontol 1991 18 3 182 189 10.1111/j.1600-051X.1991.tb01131.x 2061418
4. Plaque growth and removal with daily toothbrushing. M De la Rosa J Zacarias Guerra DA Johnston AW Radike, J Periodontol 1979 50 12 661 664 294479
5. Much dentistry qualifies for medical insurance. RS Brown KL Schwabacher, Dent Econ 1991 81 3 33 34 36 2019308
6. Oral hygiene and gingivitis in a Swedish adult population 1983 and 1993. A Hugoson O Norderyd C Slotte H Thorstensson, J Clin Periodontol 1973 25 10 807 812 10.1111/j.1600-051X.1998.tb02374.x
7. Mechanical and hygiene practices. A Frandsen, Dental plaque control measures and oral hygiene practices D.V. Oxford: IRL Pr, Löe HK, 1986 93 116
8. Chemotherapeutic agents for controlling plaque and gingivitis. ID Mandel, J Clin Periodontol 1988 15 8 488 498 10.1111/j.1600-051X.1988.tb01020.x 3053790 (Pubitemid 18248206)
9. Resolution of interdental inflammation with 2 different modes of plaque control. T Kocher H Sawaf M Warncke A Welk, J Clin Periodontol 2000 27 12 883 888 10.1034/j.1600-051x.2000.027012883.x 11140554
10. The effect of a polyhexamethylene biguanide mouthrinse compared with a triclosan rinse and a chlorhexidine rinse on bacterial counts and 4-day plaque re-growth. A Welk CH Splieth G Schmidt-Martens C Schwahn T Kocher A Kramer M Rosin, J Clin Periodontol 2005 32 5 499 505 10.1111/j.1600-051X.2005.00702.x 15842266 (Pubitemid 40627358)
11. Chlorhexidine compared with other locally delivered antimicrobials. A short review. M Addy, J Clin Periodontol 1986 13 10 957 964 10.1111/j.1600-051X. 1986.tb01434.x 3540026
12. DNA damage in multiple organs after exposure to chlorhexidine in Wistar rats. TF Grassi EA Camargo DM Salvadori ME Marques DA Ribeiro, Int J Hyg Environ Health 2007 210 2 163 167 10.1016/j.ijheh.2006.09.001 17084670 (Pubitemid 46187200)
13. Plasmids and bacterial resistance to biocides. AD Russell, Journal of Applied Microbiology 1997 83 2 155 165 10.1046/j.1365-2672.1997.00198.x 9281819
14. Lactoperoxidase, the peroxidase in the salivary gland. M Morrison WF Steele, Biology of the mouth Washington, D.C.: American Association for the Advancement of Science, Person P, 1968
15. Lactoperoxidase: structure and catalytic properties. EL Thomas PM Bozeman DB Learn, Peroxidases in Chemistry and Biology Boca Raton, FL.: CRC Press, Everse J, Everse KE, Grisham MB, 1991 123 142
16. Human salivary peroxidase and bovine lactoperoxidase are cross-reactive. B Mansson-Rahemtulla F Rahemtulla MG Humphreys-Beher, J Dent Res 1990 69 12 1839 1846 1701181
17. Origin, structure, and biological activities of peroxidases in human saliva. R Ihalin V Loimaranta J Tenovuo, Arch Biochem Biophys 2006 445 2 261 268 10.1016/j.abb.2005.07.004 16111647 (Pubitemid 43082219)
18. Lactoperoxidase-catalyzed oxidation of thiocyanate: equilibria between oxidized forms of thiocyanate. EL Thomas, Biochemistry 1981 20 11 3273 3280 10.1021/bi00514a045 7248282
19. Susceptibility of anaerobic microorganisms to hypothiocyanite produced by lactoperoxidase. P Courtois P Majerus M Labbe A Vanden Abbeele E Yourassowsky M Pourtois, Acta Stomatol Belg 1992 89 3 155 162 1481764
20. Effect of human saliva on glucose uptake by Streptococcus mutans and other oral microorganisms. GR Germaine LM Tellefson, Infect Immun 1981 31 2 598 607 7012014
21. Effects of variations in pH and hypothiocyanite concentrations on S. mutans glucose metabolism. B Mansson-Rahemtulla DC Baldone KM Pruitt F Rahemtulla, J Dent Res 1987 66 2 486 491 3040825
22. Antibacterial effect of myeloperoxidase against Streptococcus mutans. J Tenovuo O Anttilla M Lumikari G Sievers, Oral Microbiol Immunol 1988 3 2 68 71 10.1111/j.1399-302X.1988.tb00084.x 2855860
23. Inhibition of the growth of Streptococcus mutans, Streptococcus sobrinus and Lactobacillus casei by oral peroxidase systems in human saliva. M Lumikari T Soukka S Nurmio J Tenovuo, Arch Oral Biol 1991 36 2 155 160 10.1016/0003-9969(91)90078-9 1905532
24. 2 system. M Lenander-Lumikari, Oral Microbiol Immunol 1992 7 5 315 320 10.1111/j.1399-302X.1992.tb00595.x 1494457
25. Inhibition of herpes simplex virus type 1, respiratory syncytial virus and echovirus type 11 by peroxidase-generated hypothiocyanite. H Mikola M Waris J Tenovuo, Antiviral Res 1995 26 2 161 171 10.1016/0166-3542(94)00073-H 7605114
26. Concentration of thiocyanate and ionizable iodine in saliva of smokers and nonsmokers. J Tenovuo KK Makinen, J Dent Res 1976 55 4 661 663 1064612
27. Comparison of salivary peroxidase system components in caries-free and caries-active naval recruits. BL Lamberts KM Pruitt ED Pederson MP Golding, Caries Res 1984 18 6 488 494 6091882
28. Limiting factors for the generation of hypothiocyanite ion, an antimicrobial agent, in human saliva. KM Pruitt J Tenovuo W Fleming M Adamson, Caries Res 1982 16 4 315 323 6956446
29. Antibacterial activity of hydrogen peroxide and the lactoperoxidase- hydrogen peroxide-thiocyanate system against oral streptococci. EL Thomas TW Milligan RE Joyner MM Jefferson, Infect Immun 1994 62 2 529 535 8300211
30. Leukocyte myeloperoxidase and salivary lactoperoxidase: identification and quantitation in human mixed saliva. EL Thomas MM Jefferson RE Joyner GS Cook CC King, J Dent Res 1994 73 2 544 555 8120219
31. Optimization of the components concentrations of the lactoperoxidase system by RSM. Y Adolphe M Jacquot M Linder AM Revol-Junelles JB Milliere, J Appl Microbiol 2006 100 5 1034 1042 10.1111/j.1365-2672.2006.02892.x 16630004
32. 2 combinations in dentifrices on plaque and gingivitis. M Rosin T Kocher A Kramer, J Clin Periodontol 2001 28 3 270 276 10.1034/j.1600-051x.2001.028003270.x 11284542
33. 2 toothpaste compared to a commercially available triclosan-containing toothpaste on oral hygiene and gingival health a 6-month home-use study. M Rosin A Kramer D Bradtke G Richter T Kocher, J Clin Periodontol 2002 29 12 1086 1091 10.1034/j.1600-051X.2002. 291207.x 12492909 (Pubitemid 41697759)
34. EN 1040 Chemical disinfectants and antiseptics. Basic bactericidal activity. Test method and requirements (phase 1). Beuth-Publishing, Berlin 1997
35. EN 1275 Chemical disinfectants and antiseptics. Basic fungicidal activity. Test method and requirements (phase 1). Beuth-Publishing, Berlin 1997
36. Effects of a lactoperoxidase system-containing toothpaste on levels of hypothiocyanite and bacteria in saliva. M Lenander-Lumikari J Tenovuo H Mikola, Caries Res 1993 27 4 285 291 8402803
37. Lactoperoxidase antibacterial system: natural occurrence, biological functions and practical applications. B Reiter G Härnulv, J Food Prot 1984 47 724 732
38. Products of thiocyanate peroxidation: properties and reaction mechanisms. J Tenovuo KM Pruitt B Mansson-Rahemtulla P Harrington DC Baldone, Biochim Biophys Acta 1986 870 3 377 384 3697357
39. Interaction of lactoperoxidase with hydrogen peroxide. Formation of enzyme intermediates and generation of free radicals. H Kohler H Jenzer, Free Radic Biol Med 1989 6 3 323 339 10.1016/0891-5849(89)90059-2 2545551 (Pubitemid 19076498)
40. Hypothiocyanite ion; the inhibitor formed by the system lactoperoxidase-thiocyanate-hydrogen peroxide. I. Identification of the inhibiting compound. H Hoogendoorn JP Piessens W Scholtes LA Stoddard, Caries Res 1977 11 2 77 84 265188
41. Hydrogen peroxide excretion by oral streptococci and effect of lactoperoxidase-thiocyanate-hydrogen peroxide. J Carlsson Y Iwami T Yamada, Infect Immun 1983 40 1 70 80 6832837
42. Susceptibility of Candida albicans to peroxidase-catalyzed oxidation products of thiocyanate, iodide and bromide. PM Majerus PA Courtois, J Biol Buccale 1992 20 4 241 245 1306188
43. Lactoperoxidase antimicrobial activity against Candida albicans. PA Samant MM Jefferson EL Thomas, J Dent Res 1999 78 Spec. Iss 1208
44. Thiocyanate mediated antifungal and antibacterial property of goat milk lactoperoxidase. MJ Benoy AK Essy B Sreekumar M Haridas, Life Sci 2000 66 25 2433 2439 10.1016/S0024-3205(00)80003-X 10894086 (Pubitemid 30314187)
45. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment. M Belazi A Velegraki T Koussidou-Eremondi D Andreadis S Hini G Arsenis C Eliopoulou E Destouni D Antoniades, Oral Microbiol Immunol 2004 19 6 347 351 10.1111/j.1399-302x.2004.00165.x 15491459 (Pubitemid 39487667)
46. Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthwash. O Nicolatou-Galitis K Dardoufas P Markoulatos A Sotiropoulou-Lontou K Kyprianou G Kolitsi G Pissakas C Skarleas V Kouloulias V Papanicolaou, J Oral Pathol Med 2001 30 8 471 480 10.1034/j.1600-0714.2001.030008471.x 11545238
47. Oral manifestations during chemotherapy for acute lymphoblastic leukemia: a case report. MF Gomes KR Kohlemann G Plens MM Silva EM Pontes JC da Rocha, Quintessence Int 2005 36 4 307 313 15835428
48. DNA identification of the pathogen of candidal aspiration pneumonia induced in the course of oral cancer therapy. T Yamamoto E Ueta T Kamatani T Osaki, J Med Microbiol 2005 54 Pt 5 493 496 10.1099/jmm.0.45769-0 15824430 (Pubitemid 40605169)
49. Oral and Intestinal Candida Colonization in Patients Undergoing Hematopoietic Stem-Cell Transplantation. I Zollner-Schwetz HW Auner A Paulitsch W Buzina PB Staber P Ofner-Kopeinig EC Reisinger H Olschewski R Krause, J Infect Dis 2008 198 1 150 153 10.1086/588827 18491972 (Pubitemid 351920302)
50. Efficacy of antiseptics and disinfectants on clinical and environmental yeast isolates in planktonic and biofilm conditions. M Theraud Y Bedouin C Guiguen JP Gangneux, J Med Microbiol 2004 53 Pt 10 1013 1018 10.1099/jmm.0.05474-0 15358824 (Pubitemid 39391970)
51. Do cancer patients with chemotherapy-induced leukopenia benefit from an antiseptic chlorhexidine-based oral rinse? A double-blind, block-randomized, controlled study. FA Pitten T Kiefer C Buth G Doelken A Kramer, J Hosp Infect 2003 53 4 283 291 10.1053/jhin.2002.1391 12660125 (Pubitemid 38002040)
52. Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis. RL Foote CL Loprinzi AR Frank JR O'Fallon S Gulavita HH Tewfik MA Ryan JM Earle P Novotny, J Clin Oncol 1994 12 12 2630 2633 7989938
53. The effectiveness of commonly used mouthwashes for the prevention of chemotherapy-induced oral mucositis: a systematic review. CM Potting R Uitterhoeve WS Op Reimer T Van Achterberg, Eur J Cancer Care (Engl) 2006 15 5 431 439 10.1111/j.1365-2354.2006.00684.x 17177899 (Pubitemid 44893370)
54. The peritoneal explant test for evaluating tissue tolerance to mouthrinses. A Welk M Rosin C Ludtke C Schwahn A Kramer G Daeschlein, Skin Pharmacol Physiol 2007 20 3 162 166 10.1159/000098703 17230056 (Pubitemid 46788288)